Salta al contenuto
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avanzata
  • PHASE I TRIAL OF A HIGHLY IMMU...
  • Citazione
  • Invia SMS
  • Invia email
  • Stampa
  • Esporta il record
    • Esporta a RefWorks
    • Esporta a EndNoteWeb
    • Esporta a EndNote
  • PLink permanente
PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES

Mostra altre versioni (1)
Dettagli Bibliografici
Autori principali: Folgori, A, Barnes, E, Aston, S, Smith, K, Brown, A, Ambrosio, M, Ammendola, V, Bartiromo, M, Capone, S, Naddeo, M, Sparacino, A, Siani, L, Traboni, C, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P
Natura: Conference item
Pubblicazione: 2009
  • Posseduto
  • Descrizione
  • Altre versioni (1)
  • Documenti analoghi
  • MARC21
Mostra 1 - 1 risultati su 1
Mostra tutte le versioni (2)
Search Result 1
PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES di Barnes, E, Antonella, F, Aston, S, Smith, K, Brown, A, Capone, S, Ambrosio, M, Harrison, G, Ammendola, V, Bartiromo, M, Traboni, C, Siani, L, Sparacino, A, Naddeo, M, Colloca, S, Cortese, R, Nicosia, A, Klenerman, P

Pubblicazione 2009
Conference item
Mostra tutte le versioni (2)

Documenti analoghi

  • PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
    di: Barnes, E, et al.
    Pubblicazione: (2009)
  • PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
    di: Barnes, E, et al.
    Pubblicazione: (2011)
  • A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
    di: Kelly, C, et al.
    Pubblicazione: (2011)
  • Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
    di: Capone, S, et al.
    Pubblicazione: (2010)
  • Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates.
    di: Capone, S, et al.
    Pubblicazione: (2010)

Opzioni di ricerca

  • Ultime ricerche
  • Ricerca avanzata

Cerca

  • Scorri il catalogo
  • Scorri in ordine alfabetico
  • Esplora selezioni
  • Materiali riservati (per i corsi)
  • Nuovi documenti

Serve aiuto?

  • Suggerimenti per la ricerca
  • Chiedi al bibliotecario
  • FAQ